Geode Capital Management
BIND

Geode Capital Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Geode Capital Management’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-59,883
Closed -$131 – 4166
2016
Q1 		$131 Sell
59,883
-141
-0.2% -$256 ﹤0.01% 3756
2015
Q4 		$137K Buy
60,024
+8,953
+18% +$36.2K ﹤0.01% 3797
2015
Q3 		$227K Buy
51,071
+48
+0.1% +$236 ﹤0.01% 3635
2015
Q2 		$285K Buy
51,023
+41
+0.1% +$254 ﹤0.01% 3447
2015
Q1 		$279K Buy
50,982
+22,178
+77% +$136K ﹤0.01% 3457
2014
Q4 		$155K Buy
28,804
+123
+0.4% +$922 ﹤0.01% 3677
2014
Q3 		$246K Sell
28,681
-20
-0.1% -$197 ﹤0.01% 3484
2014
Q2 		$378K Sell
28,701
-3,430
-11% -$33.6K ﹤0.01% 3287
2014
Q1 		$384K Buy
32,131
+1,605
+5% +$21K ﹤0.01% 3260
2013
Q4 		$460K Buy
+30,526
New +$388K ﹤0.01% 3127

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FMA
FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Geode Capital Management's BIND Position: Q2 2016 in Review

Geode Capital Management sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 59,883 shares — an estimated $131 sold.

Geode Capital Management first reported a position in BIND in Q4 2013 and held it in 10 quarters. The position peaked at $460K in Q4 2013. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

  • Geode Capital Management reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
  • Geode Capital Management sold 59,883 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $131.
  • Geode Capital Management first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 10 quarters.
  • Geode Capital Management's BIND THERAPEUTICS INC position peaked at $460K in Q4 2013.
  • 21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.